Johl Sukhjit S, Burgett Richard A
Oculofacial Surgery, Department of Ophthalmology, The Permanente Medical Group, Inc., Sacramento, California 95815, USA.
Curr Opin Ophthalmol. 2006 Oct;17(5):471-9. doi: 10.1097/01.icu.0000243021.20499.4b.
Facial aging results from multiple microscopic (histopathologic) and macroscopic (anatomic) changes. Whereas skin care and traditional surgery have much to offer patients desiring cosmetic improvement, they can fail to adequately address certain signs of facial aging. Soft-tissue augmentation with dermal fillers can successfully address these signs of aging by filling soft-tissue defects caused by age, scar formation, or disease. All dermal fillers aim to achieve the same goal: long-lasting soft-tissue augmentation without side effects. Each dermal filler preparation available for patient use has unique compositions and characteristics that impact its proper handling, therapeutic results, potential complications, and, ultimately, its ideal use. This review surveys the currently available preparations for soft-tissue augmentation.
A review of the medical literature and manufacturers' information are included for dermal fillers currently approved for use by the US Food and Drug Administration. The composition, use, and potential limitation of each available preparation are reviewed.
Dermal filling agents offer an excellent option for management of certain facial cosmetic changes. Since a wide range of products with significantly different characteristics is available, the treating physician should have sound knowledge of them all.
面部衰老由多种微观(组织病理学)和宏观(解剖学)变化引起。虽然皮肤护理和传统手术能为希望改善容貌的患者提供很多帮助,但它们可能无法充分解决某些面部衰老迹象。使用真皮填充剂进行软组织填充可以通过填充由年龄、瘢痕形成或疾病导致的软组织缺陷,成功解决这些衰老迹象。所有真皮填充剂都旨在实现同一个目标:实现持久的软组织填充且无副作用。每种可供患者使用的真皮填充剂制剂都有独特的成分和特性,这些会影响其正确使用、治疗效果、潜在并发症以及最终的理想用途。本综述对目前可用的软组织填充制剂进行了概述。
本综述纳入了美国食品药品监督管理局目前批准使用的真皮填充剂的医学文献和制造商信息,并对每种可用制剂的成分、用途和潜在局限性进行了综述。
真皮填充剂为处理某些面部美容变化提供了一个极佳选择。由于有多种特性差异显著的产品可供选择,治疗医生应该对所有这些产品有充分的了解。